The Health Benefits of Drinking Kombucha Kombucha is bubbly fermented tea that’s perhaps most widely known for its probiotic ...

Shares of small biotech 89bioETNB nearly doubled Thursday after RocheRHHBY agreed to buy the MASH drug developer in a deal worth up to $3.5 billion.89bio is working on a treatment for MASH, or ...

The firm, which so far has focused on cancer, expects to file an IND application for a treatment for tyrosinemia type I and alkaptonuria next year.

A new type of weight loss jab can help maintain weight reductions by tackling the underlying causes of obesity, scientists ...

The star of the acquisition, which includes a contingent value right of $6 per share, is pegozafermin, an FGF21 analog in ...

As a potential first-in-class, AI-designed oral GLP-1 receptor agonist (GLP-1RA), MDR-001 represents a breakthrough in drug discovery, demonstrating how AI can reshape traditional R&D pathways and ...

Brenner has also shown the longevity-boosting promise of NAD in his research. In 2007, he conducted an experiment showing ...

A new type of weight loss jab could tackle obesity without people needing to change their eating habits, experts have claimed ...

“Because it acts on these fundamental pathways, weight regain is less likely. RES-010 is pioneering a new class of RNA ...

Roche is seeking to catch up with Novo Nordisk A/S and Eli Lilly & Co., makers of multibillion-dollar blockbusters Wegovy and ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: 4 Biotech Stocks at the Cutting Edge of Drug Delivery (MDCX, RNA, NBTX, ARWR) ...

Metformin has been prescribed to people with type 2 diabetes to manage blood sugar for more than 60 years, but scientists ...